A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

NCT00780975 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Poor recruitment

Conditions

Prostate Cancer

Interventions

DRUG: Aplidin (plitidepsin)

Sponsor

PharmaMar